<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>WhatsTrading.com &#187; Pharmaceuticals &amp; Biotechnology</title>
	<atom:link href="http://whatstrading.com/category/all-symbols/health-care/pharmaceuticals-biotechnology/feed/" rel="self" type="application/rss+xml" />
	<link>http://whatstrading.com</link>
	<description>Objective Real Time Market Intelligence</description>
	<lastBuildDate>Fri, 25 May 2012 20:21:48 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Idenix Pharmaceuticals Inc (IDIX) $9.85 -2.28%</title>
		<link>http://whatstrading.com/2012/05/25/idenix-pharmaceuticals-inc-idix-9-85-2-28/</link>
		<comments>http://whatstrading.com/2012/05/25/idenix-pharmaceuticals-inc-idix-9-85-2-28/#comments</comments>
		<pubDate>Fri, 25 May 2012 16:10:35 +0000</pubDate>
		<dc:creator>fredruffy</dc:creator>
				<category><![CDATA[All Stocks]]></category>
		<category><![CDATA[Pharmaceuticals & Biotechnology]]></category>
		<category><![CDATA[Small Cap Stocks]]></category>

		<guid isPermaLink="false">http://whatstrading.com/2012/05/25/idenix-pharmaceuticals-inc-idix-9-85-2-28/</guid>
		<description><![CDATA[<p>Idenix (IDIX) loses 27 cents to $9.81 and an investor apparently sells 8,000 July 7.5 puts on the biotech at 55 cents to buy 8,000 Jul 12.5 &#8211; 17.5 call spread for 90 cents. The three-way, for a 35 cent  <a href="/wp-login.php?action=register">(register to read more ...)</a> [...]]]></description>
			<content:encoded><![CDATA[<p>Idenix (IDIX) loses 27 cents to $9.81 and an investor apparently sells 8,000 July 7.5 puts on the biotech at 55 cents to buy 8,000 Jul 12.5 &#8211; 17.5 call spread for 90 cents. The three-way, for a 35 cent  <a href="/wp-login.php?action=register">(register to read more ...)</a> [...]]]></content:encoded>
			<wfw:commentRss>http://whatstrading.com/2012/05/25/idenix-pharmaceuticals-inc-idix-9-85-2-28/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Auxillium Pharmaceuticals Inc (AUXL) $18.61 +2.37%</title>
		<link>http://whatstrading.com/2012/05/11/auxillium-pharmaceuticals-inc-auxl-18-61-2-37/</link>
		<comments>http://whatstrading.com/2012/05/11/auxillium-pharmaceuticals-inc-auxl-18-61-2-37/#comments</comments>
		<pubDate>Fri, 11 May 2012 16:08:55 +0000</pubDate>
		<dc:creator>fredruffy</dc:creator>
				<category><![CDATA[All Stocks]]></category>
		<category><![CDATA[Pharmaceuticals & Biotechnology]]></category>
		<category><![CDATA[Small Cap Stocks]]></category>

		<guid isPermaLink="false">http://whatstrading.com/2012/05/11/auxillium-pharmaceuticals-inc-auxl-18-61-2-37/</guid>
		<description><![CDATA[<p>Auxillium Pharmaceuticals (AUXL) is up 44 cents to $18.62 and a May &#8211; Jun 20 call spread is apparently bought on the stock for $1.30, 2324X. The activity probably rolls a bullish position after the Malvern, PA biotech released earnings  <a href="/wp-login.php?action=register">(register to read more ...)</a> [...]]]></description>
			<content:encoded><![CDATA[<p>Auxillium Pharmaceuticals (AUXL) is up 44 cents to $18.62 and a May &#8211; Jun 20 call spread is apparently bought on the stock for $1.30, 2324X. The activity probably rolls a bullish position after the Malvern, PA biotech released earnings  <a href="/wp-login.php?action=register">(register to read more ...)</a> [...]]]></content:encoded>
			<wfw:commentRss>http://whatstrading.com/2012/05/11/auxillium-pharmaceuticals-inc-auxl-18-61-2-37/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Protalix BioTherapeutics Inc (PLX) $6.99 +12.92%</title>
		<link>http://whatstrading.com/2012/05/02/protalix-biotherapeutics-inc-plx-6-99-12-92/</link>
		<comments>http://whatstrading.com/2012/05/02/protalix-biotherapeutics-inc-plx-6-99-12-92/#comments</comments>
		<pubDate>Wed, 02 May 2012 17:10:26 +0000</pubDate>
		<dc:creator>fredruffy</dc:creator>
				<category><![CDATA[All Stocks]]></category>
		<category><![CDATA[Pharmaceuticals & Biotechnology]]></category>
		<category><![CDATA[Small Cap Stocks]]></category>

		<guid isPermaLink="false">http://whatstrading.com/2012/05/02/protalix-biotherapeutics-inc-plx-6-99-12-92/</guid>
		<description><![CDATA[<p>Protalix BioTherapeutics (PLX) is up 81 cents to $7 in active trading of more than 10 million shares and implied volatility in the options on the biotech is down sharply after the FDA approved an orphan drug for treating Gaucher  <a href="/wp-login.php?action=register">(register to read more ...)</a> [...]]]></description>
			<content:encoded><![CDATA[<p>Protalix BioTherapeutics (PLX) is up 81 cents to $7 in active trading of more than 10 million shares and implied volatility in the options on the biotech is down sharply after the FDA approved an orphan drug for treating Gaucher  <a href="/wp-login.php?action=register">(register to read more ...)</a> [...]]]></content:encoded>
			<wfw:commentRss>http://whatstrading.com/2012/05/02/protalix-biotherapeutics-inc-plx-6-99-12-92/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pfizer  Inc (PFE) $22.86 -0.95%</title>
		<link>http://whatstrading.com/2012/04/30/pfizer-inc-pfe-22-86-0-95/</link>
		<comments>http://whatstrading.com/2012/04/30/pfizer-inc-pfe-22-86-0-95/#comments</comments>
		<pubDate>Mon, 30 Apr 2012 19:49:10 +0000</pubDate>
		<dc:creator>fredruffy</dc:creator>
				<category><![CDATA[All Stocks]]></category>
		<category><![CDATA[Large Cap Stocks]]></category>
		<category><![CDATA[Pharmaceuticals & Biotechnology]]></category>

		<guid isPermaLink="false">http://whatstrading.com/2012/04/30/pfizer-inc-pfe-22-86-0-95/</guid>
		<description><![CDATA[<p>Pfizer (PFE) loses 19 cents to $22.89 on relatively light volume of 23 million shares, even as the drugmaker&#8217;s quarterly earnings report looms. The company is due to report tomorrow morning. Options on the stock are busy ahead of the  <a href="/wp-login.php?action=register">(register to read more ...)</a> [...]]]></description>
			<content:encoded><![CDATA[<p>Pfizer (PFE) loses 19 cents to $22.89 on relatively light volume of 23 million shares, even as the drugmaker&#8217;s quarterly earnings report looms. The company is due to report tomorrow morning. Options on the stock are busy ahead of the  <a href="/wp-login.php?action=register">(register to read more ...)</a> [...]]]></content:encoded>
			<wfw:commentRss>http://whatstrading.com/2012/04/30/pfizer-inc-pfe-22-86-0-95/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Onyx Pharmaceuticals Inc (ONXX) $47.35 +9.00%</title>
		<link>http://whatstrading.com/2012/04/25/onyx-pharmaceuticals-inc-onxx-47-35-9-00/</link>
		<comments>http://whatstrading.com/2012/04/25/onyx-pharmaceuticals-inc-onxx-47-35-9-00/#comments</comments>
		<pubDate>Wed, 25 Apr 2012 19:44:57 +0000</pubDate>
		<dc:creator>fredruffy</dc:creator>
				<category><![CDATA[All Stocks]]></category>
		<category><![CDATA[Mid Cap Stocks]]></category>
		<category><![CDATA[Pharmaceuticals & Biotechnology]]></category>

		<guid isPermaLink="false">http://whatstrading.com/2012/04/25/onyx-pharmaceuticals-inc-onxx-47-35-9-00/</guid>
		<description><![CDATA[<p>Onyx Pharmaceuticals (ONXX) sees a morning spike and rallies to 52-week highs on high volume of 5.7 million shares after Reuters ran a piece suggesting Bayer might be intrest in the biotech. ONXXY is up $4 to $47.44 and ptions  <a href="/wp-login.php?action=register">(register to read more ...)</a> [...]]]></description>
			<content:encoded><![CDATA[<p>Onyx Pharmaceuticals (ONXX) sees a morning spike and rallies to 52-week highs on high volume of 5.7 million shares after Reuters ran a piece suggesting Bayer might be intrest in the biotech. ONXXY is up $4 to $47.44 and ptions  <a href="/wp-login.php?action=register">(register to read more ...)</a> [...]]]></content:encoded>
			<wfw:commentRss>http://whatstrading.com/2012/04/25/onyx-pharmaceuticals-inc-onxx-47-35-9-00/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Sequenom Inc (SQNM) $5.04 +7.69%</title>
		<link>http://whatstrading.com/2012/04/20/sequenom-inc-sqnm-5-04-7-69/</link>
		<comments>http://whatstrading.com/2012/04/20/sequenom-inc-sqnm-5-04-7-69/#comments</comments>
		<pubDate>Fri, 20 Apr 2012 16:05:00 +0000</pubDate>
		<dc:creator>fredruffy</dc:creator>
				<category><![CDATA[All Stocks]]></category>
		<category><![CDATA[Pharmaceuticals & Biotechnology]]></category>
		<category><![CDATA[Small Cap Stocks]]></category>

		<guid isPermaLink="false">http://whatstrading.com/2012/04/20/sequenom-inc-sqnm-5-04-7-69/</guid>
		<description><![CDATA[<p>Sequenom (SQNM) adds 35 cents to $5.03 on heavy volume of 4 million shares and options order flow on the biotech is bullish Friday, with 4,300 calls and 400 puts traded so far &#8212; a ratio of more than ten-to-one.  <a href="/wp-login.php?action=register">(register to read more ...)</a> [...]]]></description>
			<content:encoded><![CDATA[<p>Sequenom (SQNM) adds 35 cents to $5.03 on heavy volume of 4 million shares and options order flow on the biotech is bullish Friday, with 4,300 calls and 400 puts traded so far &#8212; a ratio of more than ten-to-one.  <a href="/wp-login.php?action=register">(register to read more ...)</a> [...]]]></content:encoded>
			<wfw:commentRss>http://whatstrading.com/2012/04/20/sequenom-inc-sqnm-5-04-7-69/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Neurocrine Biosciences Inc (NBIX) $8.40 -6.56%</title>
		<link>http://whatstrading.com/2012/03/27/neurocrine-biosciences-inc-nbix-8-40-6-56/</link>
		<comments>http://whatstrading.com/2012/03/27/neurocrine-biosciences-inc-nbix-8-40-6-56/#comments</comments>
		<pubDate>Tue, 27 Mar 2012 13:52:39 +0000</pubDate>
		<dc:creator>fredruffy</dc:creator>
				<category><![CDATA[All Stocks]]></category>
		<category><![CDATA[Pharmaceuticals & Biotechnology]]></category>
		<category><![CDATA[Small Cap Stocks]]></category>

		<guid isPermaLink="false">http://whatstrading.com/2012/03/27/neurocrine-biosciences-inc-nbix-8-40-6-56/</guid>
		<description><![CDATA[<p>Neucrine Biosciences (NBIX) loses 67 cents to $8.32 and one strategist sells 5,000 Apr 7 puts on the stock at 10 cents per contract and sold 10,000 April 9 calls at 30 cents. The 1X2 strangle probably offsets a position  <a href="/wp-login.php?action=register">(register to read more ...)</a> [...]]]></description>
			<content:encoded><![CDATA[<p>Neucrine Biosciences (NBIX) loses 67 cents to $8.32 and one strategist sells 5,000 Apr 7 puts on the stock at 10 cents per contract and sold 10,000 April 9 calls at 30 cents. The 1X2 strangle probably offsets a position  <a href="/wp-login.php?action=register">(register to read more ...)</a> [...]]]></content:encoded>
			<wfw:commentRss>http://whatstrading.com/2012/03/27/neurocrine-biosciences-inc-nbix-8-40-6-56/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Arena Pharmaceuticals Inc (ARNA) $3.02 +25.31%</title>
		<link>http://whatstrading.com/2012/03/26/arena-pharmaceuticals-inc-arna-3-02-25-31/</link>
		<comments>http://whatstrading.com/2012/03/26/arena-pharmaceuticals-inc-arna-3-02-25-31/#comments</comments>
		<pubDate>Mon, 26 Mar 2012 15:37:51 +0000</pubDate>
		<dc:creator>fredruffy</dc:creator>
				<category><![CDATA[All Stocks]]></category>
		<category><![CDATA[Pharmaceuticals & Biotechnology]]></category>
		<category><![CDATA[Small Cap Stocks]]></category>

		<guid isPermaLink="false">http://whatstrading.com/2012/03/26/arena-pharmaceuticals-inc-arna-3-02-25-31/</guid>
		<description><![CDATA[<p>Arena Pharmaceuticals (ARNA) is rallying today and implied volatility in the options on the stock is up sharply amid high call volume after the European Medicines Agency accepted the biotech&#8217;s Lorcaserin as a weight loss drug. ARNA is up 57  <a href="/wp-login.php?action=register">(register to read more ...)</a> [...]]]></description>
			<content:encoded><![CDATA[<p>Arena Pharmaceuticals (ARNA) is rallying today and implied volatility in the options on the stock is up sharply amid high call volume after the European Medicines Agency accepted the biotech&#8217;s Lorcaserin as a weight loss drug. ARNA is up 57  <a href="/wp-login.php?action=register">(register to read more ...)</a> [...]]]></content:encoded>
			<wfw:commentRss>http://whatstrading.com/2012/03/26/arena-pharmaceuticals-inc-arna-3-02-25-31/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Targacept Inc (TRGT) $5.58 -24.70%</title>
		<link>http://whatstrading.com/2012/03/20/targacept-inc-trgt-5-58-24-70/</link>
		<comments>http://whatstrading.com/2012/03/20/targacept-inc-trgt-5-58-24-70/#comments</comments>
		<pubDate>Tue, 20 Mar 2012 14:33:40 +0000</pubDate>
		<dc:creator>fredruffy</dc:creator>
				<category><![CDATA[All Stocks]]></category>
		<category><![CDATA[Pharmaceuticals & Biotechnology]]></category>
		<category><![CDATA[Small Cap Stocks]]></category>
		<category><![CDATA[SSR]]></category>

		<guid isPermaLink="false">http://whatstrading.com/2012/03/20/targacept-inc-trgt-5-58-24-70/</guid>
		<description><![CDATA[<p>Targacept (TRGT) is off $1.83 to $5.58 on heavy volume of 5.3 million shares after the company, along with partner Astrazenca, halted the development of an experimental antidepressant following disappointing results from a late-stage trial. TRGT tanked on the news  <a href="/wp-login.php?action=register">(register to read more ...)</a> [...]]]></description>
			<content:encoded><![CDATA[<p>Targacept (TRGT) is off $1.83 to $5.58 on heavy volume of 5.3 million shares after the company, along with partner Astrazenca, halted the development of an experimental antidepressant following disappointing results from a late-stage trial. TRGT tanked on the news  <a href="/wp-login.php?action=register">(register to read more ...)</a> [...]]]></content:encoded>
			<wfw:commentRss>http://whatstrading.com/2012/03/20/targacept-inc-trgt-5-58-24-70/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Illumina Inc (ILMN) $50.19 +0.52%</title>
		<link>http://whatstrading.com/2012/03/19/illumina-inc-ilmn-50-19-0-52/</link>
		<comments>http://whatstrading.com/2012/03/19/illumina-inc-ilmn-50-19-0-52/#comments</comments>
		<pubDate>Mon, 19 Mar 2012 15:40:02 +0000</pubDate>
		<dc:creator>fredruffy</dc:creator>
				<category><![CDATA[All Stocks]]></category>
		<category><![CDATA[Mid Cap Stocks]]></category>
		<category><![CDATA[Pharmaceuticals & Biotechnology]]></category>

		<guid isPermaLink="false">http://whatstrading.com/2012/03/19/illumina-inc-ilmn-50-19-0-52/</guid>
		<description><![CDATA[<p>Illumina (ILMN) ticks 31 cents higher to $50.24 in active trading of 1.1 million shares after the company filed a proxy statement and sent a letter urging that stockholders reject Roche&#8217;s hostile takeover attempt. Options on the biotech are seeing  <a href="/wp-login.php?action=register">(register to read more ...)</a> [...]]]></description>
			<content:encoded><![CDATA[<p>Illumina (ILMN) ticks 31 cents higher to $50.24 in active trading of 1.1 million shares after the company filed a proxy statement and sent a letter urging that stockholders reject Roche&#8217;s hostile takeover attempt. Options on the biotech are seeing  <a href="/wp-login.php?action=register">(register to read more ...)</a> [...]]]></content:encoded>
			<wfw:commentRss>http://whatstrading.com/2012/03/19/illumina-inc-ilmn-50-19-0-52/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

